For the quarter ended July 2026, Phreesia (PHR) reported revenue of $129.46 million, up 10.4% over the same period last year. EPS came in at $0.03, compared to $0.01 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $129.63 million, representing a surprise of -0.13%. The company delivered an EPS surprise of -72.73%, with the consensus EPS estimate being $0.11.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Phreesia performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
-
Average healthcare services Clients: 4,744 versus 4,747 estimated by four analysts on average.
-
Total managed payments: $1.63 billion compared to the $1.76 billion average estimate based on two analysts.
-
Revenue- Subscription and related services: $52.7 million versus the five-analyst average estimate of $52.98 million. The reported number represents a year-over-year change of -1.9%.
-
Revenue- Network solutions: $38.27 million versus the five-analyst average estimate of $35.58 million.
-
Revenue- Payment solutions: $38.49 million versus the five-analyst average estimate of $40.46 million.
View all Key Company Metrics for Phreesia here>>>
Shares of Phreesia have returned +3.5% over the past month versus the Zacks S&P 500 composite's +2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Phreesia, Inc. (PHR) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
